GRAYCE
Michael Bawn is a Lead Analyst at GRAYCE, specializing in the pharmaceuticals sector since February 2021. Bawn has significant experience in finance, focusing on the creation and design of a Deal Management System and participating in data consolidation and visualization projects. Previously, as a Senior Analyst, Bawn contributed to the integration of financial systems following a merger and worked on a proof of concept for a system replacement. Bawn's earlier role as a Project Analyst involved centralizing data from various source systems into a data lake. Concurrently, Bawn serves as a Business Analyst at AstraZeneca, addressing operations and finance to enhance business value through various projects. Bawn holds a degree in Economics and Finance with a focus on Statistics from Newcastle University, earned between 2016 and 2019.